US Stock MarketDetailed Quotes

BDTX Black Diamond Therapeutics

Watchlist
  • 3.310
  • +0.090+2.80%
Close Oct 18 16:00 ET
  • 3.240
  • -0.070-2.11%
Post 20:01 ET
187.03MMarket Cap-2206P/E (TTM)

Black Diamond Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-2.49%-14.73M
-5.83%-21.2M
21.59%-66.72M
36.39%-13.96M
-11.45%-18.36M
20.47%-14.37M
29.96%-20.03M
15.04%-85.08M
8.76%-21.94M
37.78%-16.48M
Net income from continuing operations
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
-6.25%-23.01M
16.48%-19.15M
18.16%-20.88M
27.41%-91.17M
18.51%-21.08M
38.27%-21.65M
Operating gains losses
----
----
2,005.88%358K
--0
6,320.00%321K
--0
--37K
342.86%17K
190.00%9K
--5K
Depreciation and amortization
-24.56%86K
-29.51%86K
-13.98%437K
-31.75%86K
-10.85%115K
-10.94%114K
-2.40%122K
147.80%508K
2.44%126K
200.00%129K
Other non cash items
5.59%737K
5.51%728K
3.08%2.81M
5.43%718K
4.42%708K
1.90%698K
0.58%690K
36.02%2.73M
-1.45%681K
16.49%678K
Change In working capital
-83.37%217K
-64.06%-4.57M
137.23%3.69M
184.17%3.93M
-22.97%1.24M
97.13%1.31M
62.92%-2.79M
-241.04%-9.9M
-70.74%-4.66M
-63.96%1.61M
-Change in prepaid assets
-116.75%-176K
-354.05%-973K
122.50%2.27M
-91.62%159K
-22.85%672K
17.17%1.05M
114.46%383K
162.53%1.02M
254.77%1.9M
9.84%871K
-Change in payables and accrued expense
53.88%1.57M
-14.83%-2.77M
156.03%4.54M
178.72%4.58M
-6.44%1.35M
120.61%1.02M
42.28%-2.41M
-178.71%-8.09M
-117.74%-5.82M
-63.56%1.45M
-Change in other current assets
----
----
--0
--0
--0
----
----
-82.22%16K
--0
1,100.00%10K
-Change in other current liabilities
-9.44%-835K
-9.28%-824K
-9.61%-3.11M
-9.56%-814K
-9.51%-783K
-9.63%-763K
-9.75%-754K
-64.70%-2.84M
-9.75%-743K
-149.13%-715K
Cash from discontinued investing activities
Operating cash flow
-2.49%-14.73M
-5.83%-21.2M
21.59%-66.72M
36.39%-13.96M
-11.45%-18.36M
20.47%-14.37M
29.96%-20.03M
15.04%-85.08M
8.76%-21.94M
37.78%-16.48M
Investing cash flow
Cash flow from continuing investing activities
-95.69%740K
-155.37%-13.73M
-69.37%16.35M
427.52%12.25M
-361.14%-37.88M
-13.29%17.18M
48.28%24.81M
-59.14%53.37M
-94.63%2.32M
-59.36%14.51M
Net PPE purchase and sale
----
----
133.88%62K
--0
-512.50%-33K
----
----
93.25%-183K
102.70%9K
100.54%8K
Net investment purchase and sale
-95.89%702K
-155.37%-13.73M
-69.59%16.28M
429.57%12.25M
-361.06%-37.85M
-14.60%17.08M
48.22%24.81M
-59.84%53.55M
-94.69%2.31M
-61.01%14.5M
Cash from discontinued investing activities
Investing cash flow
-95.69%740K
-155.37%-13.73M
-69.37%16.35M
427.52%12.25M
-361.14%-37.88M
-13.29%17.18M
48.28%24.81M
-59.14%53.37M
-94.63%2.32M
-59.36%14.51M
Financing cash flow
Cash flow from continuing financing activities
21.38M
7,998.04%4.13M
40,539.55%71.93M
-64.29%-46K
138,221.15%71.93M
0
-66.67%51K
-75.72%177K
-28K
-18.75%52K
Net common stock issuance
--21.01M
--3.98M
--71.85M
--0
--71.85M
--0
--0
--0
--0
----
Proceeds from stock option exercised by employees
--364K
194.12%150K
-53.67%82K
-64.29%-46K
48.08%77K
--0
-66.67%51K
-75.72%177K
---28K
-18.75%52K
Cash from discontinued financing activities
Financing cash flow
--21.38M
7,998.04%4.13M
40,539.55%71.93M
-64.29%-46K
138,221.15%71.93M
--0
-66.67%51K
-75.72%177K
---28K
-18.75%52K
Net cash flow
Beginning cash position
-34.90%26.24M
60.76%57.04M
-47.06%35.48M
6.66%58.8M
-24.42%43.12M
-27.11%40.31M
-47.06%35.48M
87.07%67.02M
15.27%55.13M
47.99%57.05M
Current changes in cash
163.34%7.39M
-738.27%-30.8M
168.36%21.56M
91.08%-1.75M
918.00%15.68M
61.23%2.81M
141.18%4.83M
-201.11%-31.54M
-202.34%-19.65M
-120.66%-1.92M
End cash Position
-21.99%33.63M
-34.90%26.24M
60.76%57.04M
60.76%57.04M
6.66%58.8M
-24.42%43.12M
-27.11%40.31M
-47.06%35.48M
-47.06%35.48M
15.27%55.13M
Free cash flow
-2.49%-14.73M
-5.83%-21.2M
21.72%-66.75M
36.39%-13.96M
-11.70%-18.4M
21.31%-14.37M
29.98%-20.03M
17.10%-85.27M
10.01%-21.94M
41.12%-16.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -2.49%-14.73M-5.83%-21.2M21.59%-66.72M36.39%-13.96M-11.45%-18.36M20.47%-14.37M29.96%-20.03M15.04%-85.08M8.76%-21.94M37.78%-16.48M
Net income from continuing operations -3.95%-19.91M12.69%-18.23M9.57%-82.44M7.92%-19.41M-6.25%-23.01M16.48%-19.15M18.16%-20.88M27.41%-91.17M18.51%-21.08M38.27%-21.65M
Operating gains losses --------2,005.88%358K--06,320.00%321K--0--37K342.86%17K190.00%9K--5K
Depreciation and amortization -24.56%86K-29.51%86K-13.98%437K-31.75%86K-10.85%115K-10.94%114K-2.40%122K147.80%508K2.44%126K200.00%129K
Other non cash items 5.59%737K5.51%728K3.08%2.81M5.43%718K4.42%708K1.90%698K0.58%690K36.02%2.73M-1.45%681K16.49%678K
Change In working capital -83.37%217K-64.06%-4.57M137.23%3.69M184.17%3.93M-22.97%1.24M97.13%1.31M62.92%-2.79M-241.04%-9.9M-70.74%-4.66M-63.96%1.61M
-Change in prepaid assets -116.75%-176K-354.05%-973K122.50%2.27M-91.62%159K-22.85%672K17.17%1.05M114.46%383K162.53%1.02M254.77%1.9M9.84%871K
-Change in payables and accrued expense 53.88%1.57M-14.83%-2.77M156.03%4.54M178.72%4.58M-6.44%1.35M120.61%1.02M42.28%-2.41M-178.71%-8.09M-117.74%-5.82M-63.56%1.45M
-Change in other current assets ----------0--0--0---------82.22%16K--01,100.00%10K
-Change in other current liabilities -9.44%-835K-9.28%-824K-9.61%-3.11M-9.56%-814K-9.51%-783K-9.63%-763K-9.75%-754K-64.70%-2.84M-9.75%-743K-149.13%-715K
Cash from discontinued investing activities
Operating cash flow -2.49%-14.73M-5.83%-21.2M21.59%-66.72M36.39%-13.96M-11.45%-18.36M20.47%-14.37M29.96%-20.03M15.04%-85.08M8.76%-21.94M37.78%-16.48M
Investing cash flow
Cash flow from continuing investing activities -95.69%740K-155.37%-13.73M-69.37%16.35M427.52%12.25M-361.14%-37.88M-13.29%17.18M48.28%24.81M-59.14%53.37M-94.63%2.32M-59.36%14.51M
Net PPE purchase and sale --------133.88%62K--0-512.50%-33K--------93.25%-183K102.70%9K100.54%8K
Net investment purchase and sale -95.89%702K-155.37%-13.73M-69.59%16.28M429.57%12.25M-361.06%-37.85M-14.60%17.08M48.22%24.81M-59.84%53.55M-94.69%2.31M-61.01%14.5M
Cash from discontinued investing activities
Investing cash flow -95.69%740K-155.37%-13.73M-69.37%16.35M427.52%12.25M-361.14%-37.88M-13.29%17.18M48.28%24.81M-59.14%53.37M-94.63%2.32M-59.36%14.51M
Financing cash flow
Cash flow from continuing financing activities 21.38M7,998.04%4.13M40,539.55%71.93M-64.29%-46K138,221.15%71.93M0-66.67%51K-75.72%177K-28K-18.75%52K
Net common stock issuance --21.01M--3.98M--71.85M--0--71.85M--0--0--0--0----
Proceeds from stock option exercised by employees --364K194.12%150K-53.67%82K-64.29%-46K48.08%77K--0-66.67%51K-75.72%177K---28K-18.75%52K
Cash from discontinued financing activities
Financing cash flow --21.38M7,998.04%4.13M40,539.55%71.93M-64.29%-46K138,221.15%71.93M--0-66.67%51K-75.72%177K---28K-18.75%52K
Net cash flow
Beginning cash position -34.90%26.24M60.76%57.04M-47.06%35.48M6.66%58.8M-24.42%43.12M-27.11%40.31M-47.06%35.48M87.07%67.02M15.27%55.13M47.99%57.05M
Current changes in cash 163.34%7.39M-738.27%-30.8M168.36%21.56M91.08%-1.75M918.00%15.68M61.23%2.81M141.18%4.83M-201.11%-31.54M-202.34%-19.65M-120.66%-1.92M
End cash Position -21.99%33.63M-34.90%26.24M60.76%57.04M60.76%57.04M6.66%58.8M-24.42%43.12M-27.11%40.31M-47.06%35.48M-47.06%35.48M15.27%55.13M
Free cash flow -2.49%-14.73M-5.83%-21.2M21.72%-66.75M36.39%-13.96M-11.70%-18.4M21.31%-14.37M29.98%-20.03M17.10%-85.27M10.01%-21.94M41.12%-16.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data